Implications of cancer evolution for drug development

Nat Rev Drug Discov. 2017 Jul;16(7):441-442. doi: 10.1038/nrd.2017.78. Epub 2017 Apr 28.

Authors

Samra Turajlic^{1

2}, Charles Swanton^{1

3}

Affiliations

¹ Translational Cancer Therapeutics Laboratory, The Francis Crick Institute, 1 Midland Rd, London NW1 1AT, UK.
² Renal and Skin Units, The Royal Marsden Hospital, London SW3 6JJ, UK.
³ Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London WC1E 6BT, UK.

PMID: 28450743
DOI: 10.1038/nrd.2017.78

No abstract available

MeSH terms

Antineoplastic Agents / pharmacology*
Drug Design*
Drug Resistance, Neoplasm*
Evolution, Molecular
Humans
Neoplasms / drug therapy*
Neoplasms / pathology

Substances

Antineoplastic Agents

Grants and funding